Popular Articles

Louisiana House Approves Bill Allowing Providers To Refuse Certain Reproductive Health Services
The Louisiana House on Tuesday voted 82-13 to approve legislation (HB 517) that would allow some health professionals to refuse to provide certain medical services that they object to on religious or moral grounds, the New Orleans Times-Picayune reports.The House-passed bill is an amended version of a measure, introduced by Rep. Bernard LeBas (D), that a House committee rejected earlier this month. The revised bill narrowed the list of procedures that can be denied, and it applies to health providers only in public facilities, not religious health facilities statewide as in the original bill. Under the bill, public health care employees would be allowed to decline to provide abortions or abortifacient drugs. They also would be allowed to refuse participation in embryonic stem cell research or cloning, euthanasia and physician-assisted suicide. Public employees would be immune from civil lawsuits and have job security under the measure.According to the Times-Picayune, Gov. Bobby Jindal"s (R) administration backed the original bill in committee, although state Health Secretary Alan Levine indicated that the bill"s original provisions were too broad. Under the original measure, health care providers would have been allowed to refuse services such as artificial insemination, sterilization, artificial reproductive technologies and "dispensation of drugs affecting the reproductive process." The original measure also would have covered both public and private health care providers (Barrow, New Orleans Times-Picayune, 5/20).Prior to passage, the House approved an amendment to narrow the scope of the bill offered by Rep. John Bel Edwards (D), who said that the original bill"s provisions were not specific enough and could pose problems for private businesses. He also said that the original bill would have posed barriers to patients seeking access to basic treatments and medications (AP/New Orleans Times-Picayune, 5/19). The measure now advances to the state Senate for debate (New Orleans Times-Picayune, 5/20).
pharmacy online
Renowned Surgeon Examines Our Most Significant Contributions To Surgery - From Crude Procedures To Precision Operations
As a result of the scientific advances and medical innovations made in the twentieth century, the United States today occupies an established and unchallenged leading role in the field of surgery. Renowned surgeon Seymour I. Schwartz, MD, gives a sweeping history of American surgical practice in "Gifted Hands: America"s Most Significant Contributions To Surgery" (Prometheus Books). He describes how surgery in the United States has advanced from the comparatively crude practices of pioneering physicians in the pre-Columbian and colonial eras to its current level of preeminence in scientific surgery today.
News of the day
Benefits From Upper Airway Surgery For Sleep Apnea Found To Equal CPAP
Adults who struggle with CPAP treatment for obstructive sleep apnea (OSA) should be considered candidates for reconstructive surgery on the upper airway, because it holds the same quality-of-life (QOL) benefits but with more permanence. This thesis is in new research published in the August 2009 edition of Otolaryngology-Head and Neck Surgery.

What Is Edema? What Causes Edema?

Edema, is swelling caused by fluid retention - excess fluid is trapped in the body"s tissues. In the UK/Ireland/Australasia and some other countries the word is spelled oedema. Swelling caused by edema commonly occurs in the hands, arms, ankles, legs and feet. It is usually linked to the venous or lymphatic systems. Edema was formerly known as dropsy or hydropsy. Edema may be generalized or local. It can appear suddenly, but usually develops subtly - the patient may first gain weight, or wake up with puffy eyes. Many patients wait until symptoms are well advanced before seeking medical help.

Exploring The Complexity Of Symbiosis In DNA And Cell Biology.

The unique association between microorganisms and their hosts, whether insects, plants, or mammals, provides a fascinating view into how microbial symbionts adapt to changing biological environments. Insights into the diversity and complexity of symbiotic relationships are the focus of the current special issue of DNA and Cell Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. The issue is available free online at http://www.liebertpub.com/dna "Symbiosis is one of the most rapidly growing fields in biology.... After decades of focusing on bacteria in pure culture, it is evident that to manage them for our benefit, we need to understand bacteria in association with the complex biological environments with which they contend in the natural world," write Jo Handelsman, PhD, Editor-in-Chief of DNA and Cell Biology, Professor at the University of Wisconsin-Madison, and President of the Rosalind Franklin Society, and Guest Editor Margaret J. McFall-Ngai, Professor at the University of Wisconsin-Madison, in their Editorial. Whole body vibration machine

Over 50 Pharmacists Trained Up For NPA's Seasonal Flu Vaccination Service.

Over 50 pharmacists have been trained to provide seasonal flu vaccinations under a private Patient Group Direction that the NPA is facilitating. Training days were conducted in London and Birmingham with further training days scheduled at the start of September 2009 in Newport, Durham, St Albans and Haydock. Raj Nutan, NPA Head of Business Development said: "Members were telling us that the burden of regulation was frustrating them if they wished to supply prescription medicines via private patient group directions. So we have embarked on developing a series of PGD opportunities that will provide them with a means of clearing the regulatory hurdle effortlessly. A bonus for NPA members is that they won"t need additional insurance - NPA Insurance already covers the pharmacist for providing this NPA service.

FDA Issues Final Regulation On Dental Amalgam.

The U.S. Food and Drug Administration issued a final regulation classifying dental amalgam and its component parts - elemental mercury and a powder alloy-used in dental fillings. While elemental mercury has been associated with adverse health effects at high exposures, the levels released by dental amalgam fillings are not high enough to cause harm in patients. The regulation classifies dental amalgam into Class II (moderate risk). By classifying a device into Class II, the FDA can impose special controls (in addition to general controls such as good manufacturing practices that apply to all medical devices regardless of risk) to provide reasonable assurance of the safety and effectiveness of the device.